MRI

The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging

By Jeff Hall

March 13th 2025

Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.

AI and bpMRI for csPCa Detection: What a New Meta-Analysis Reveals

By Jeff Hall

March 10th 2025

Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients

By Jeff Hall

March 7th 2025

Is Ultrasound or MRI More Effective for Diagnosing Peripheral Nerve Disorders in the Upper Extremities?

By Jeff Hall

March 6th 2025

Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa

By Jeff Hall

March 6th 2025

Latest CME Events & Activities

2025 GU Satellite Symposia in San Francisco

February 13-14, 2025

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

26th Annual International Lung Cancer Congress®

July 25-26, 2025

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure